New tests to diagnose glaucoma and related eye problems
Part of Eyes & vision, Hormones & metabolism clinical trials.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign consent for it
- You’re either a healthy volunteer or have one of these eye conditions: glaucoma/glaucoma suspect, age-related macular degeneration, diabetic retinopathy, or central serous chorioretinopathy
- If you’re joining the Alzheimer’s (AD) sub-study, you must be diagnosed with Alzheimer’s disease or mild cognitive impairment (MCI)
- You should not have other health problems that affect vision tests (like prior stroke) or eye measurements (retinal thickness) besides glaucoma
- Your eyes must be able to see and focus clearly: no strabismus, nystagmus, or anything blocking the view of the back of the eye
- You should not have had major eye trauma or intraocular surgery recently (except routine glaucoma procedures or cataract surgery done at least 3 months ago)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study tests a new camera technology that takes detailed pictures of the back of your eye (retina) to better understand eye diseases. Researchers want to compare images from people with eye conditions like diabetes-related eye disease, glaucoma, or age-related macular degeneration with healthy volunteers to see how the new imaging works.
This study uses advanced eye scans to compare the eyes of people with glaucoma against those with healthy eyes. It aims to find better ways to detect and monitor glaucoma, which could help preserve vision.
This study uses a special imaging test (OCT angiography) to look at blood flow around the optic nerve in people with advanced glaucoma. It aims to better understand how glaucoma affects eye circulation, which may help improve future care.
This study tests an artificial intelligence (AI) system that looks at eye images to find early signs of glaucoma, a condition that can damage the optic nerve and lead to vision loss. The goal is to see if the AI can accurately tell apart people with glaucoma from those with healthy eyes, which could help with earlier diagnosis and treatment.
This trial studies whether a new, very high-resolution and high-speed eye scan can be used for people with eye problems or for healthy volunteers. It may help doctors better “see” eye structures more clearly to guide care.
This study looks at different ways to measure how glaucoma affects your vision over time by comparing visual field results. It may help researchers find better models to track progression so treatment decisions can be made more accurately.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.